Orbimed Advisors of New York is now preparing to launch its second Pan Asia Healthcare Fund by the end of 2013. The company is earmarking US$500 million to invest in fast growing Asian markets such as India and China.
The fund can be infused with 65% of funds sourced from India. According to OrbiMed's founder and current Managing Partner Samuel Isaly, "We're looking mainly to make approximately ten to twelve transactions. We are running out of money for the existing fund." The infusion would increase the size to double its original US$188 million fund launched back in 2008.
Private equity funds have increased their exposure to four times its size in India's healthcare sector for 2012. The funds are hedging that as the country's consumer spending rises, so to would their need for quality primary healthcare estimated to have a market size of US$30 billion. Others such as Goldman Sachs Group Inc, Warburg Pincus LLC, Sequoia Capital and the Government of Singapore Investment Corp have put in over US$520 million into the industry already.
Join the Conversation